Applied Genetic Technologies Corp (NASDAQ: AGTC) stock was up 19% to $6.17 in the pre-market session.
Applied Genetic Technologies Corp (NASDAQ: AGTC) is a clinical-stage biotechnology company focused on addressing debilitating and often fatal diseases of the eyes, ears, and nervous system (CNS). AGTC can design and construct all critical elements of gene therapy and combine them into customized treatments specifically designed to address patient needs.
Most Recent Developments
- On February 04, 2021, Applied Genetic Technologies Corporation (Nasdaq: AGTC) informed investors it would report fourth-quarter fiscal 2020 earnings before the market opens Today February 11, 2021. AGTC management will host a call to review results and provide a corporate update. The conference call will begin at 8:00 AM Eastern Time on the same day.
Call 877-407-6184 (US) or 201-389-0877 (outside the US) to access the call. There will be a live webcast available on the Investor Relations website, http://ir.agtc.com/events-and-presentations. You may begin logging in about 10 minutes before start time. Archived webcasts will be accessible through the Events and Presentations section of the Company’s website.
- On the same day earlier this month, the Company revealed that Sue Washer, President & CEO, and Dave Knop, Vice President of Process Development, won first place in the Cell and Gene Therapies category in the inaugural Readers’ Choice Awards program of BioProcess International (BPI) magazine.
Investing in the stock market can be quite confusing, catching even experienced traders by surprise. The market can often take a sudden reversal even when results are as projected. That often leads to doubt and speculation. A stock’s historical price performance may prove valuable at such times. Additionally, knowledge of either the short-term or long-term trends of stock would be useful. Since the beginning of the quarter, Applied Genetic Technologies Corp (NASDAQ: AGTC) share prices are down -4.81% but are up 17.05% during the past seven trading days. The shares have been trading at -89.97% over the last 6 months while being at 25.92% over the previous year.